Bello E, Caramelo C, López M D, Soldevilla M J, Gonzalez-Pacheco F R, Rovira A, Delgado R G, Alcazar J M, Martell N, González J, Ruilope L M, Casado S
Hypertension Units, Fundación Jiménez Díaz, Madrid, Spain.
Am J Kidney Dis. 1999 Jun;33(6):1018-25. doi: 10.1016/S0272-6386(99)70137-X.
Despite evidence from individuals with diabetes mellitus or reduced renal mass, the actual relationship between protein- or amino acid-induced changes in renal function and urinary albumin excretion (UAE) is largely unknown in subjects without renal disease. In humans, infusions of l-arginine have been used recently in vascular and renal pathophysiological studies. The present study was undertaken to analyze the mechanisms involved in a particular effect; namely, the behavior of UAE during amino acid loading. A prospective interventional protocol was performed on 10 healthy adults by means of an intravenous infusion of l-arginine. The main results show that l-arginine induced a significant increase in UAE from 13.1 +/- 3.8 before to 53.3 +/- 11.1 microgram/min after the infusion (P < 0.005). This increment was simultaneous to an increase in glomerular filtration rate (GFR) and renal plasma flow (RPF). Furthermore, l-arginine markedly increased the urinary excretion of beta2-microglobulin. UAE correlated significantly with GFR (r = 0. 738; P = 0.014) and RPF (r = 0.942; P < 0.0001), but not with urinary beta2-microglobulin (r = 0.05; P = not significant). Furthermore, marked differences (P = 0.001) were found between the percentage of increase in UAE (306.8% +/- 163.2%) with respect to either albumin filtered load (FLAlb; 57.9% +/- 16.3%) and beta2-microglobulin excretion (1,088.5% +/- 424.6%). No changes were found in vehicle-infused individuals. In conclusion, the present study shows, in controlled conditions, that l-arginine infusion induces a relevant increase in UAE in healthy individuals that significantly exceeds that expected from the increase in GFR alone. The intense and simultaneous increment in beta2-microglobulin excretion strongly suggests that the effect of l-arginine on UAE is, in a relevant part, mediated through a blockade in the tubular protein reabsorption pathways. However, the profound differences observed in the changes induced by l-arginine on UAE and beta2-microglobulin excretion and the differences in the correlation of UAE and beta2-microglobulin with respect to GFR suggest that substantial diversity exists in the mechanisms by which l-arginine affects the renal management of albumin and beta2-microglobulin. These findings are relevant for understanding the renal response to l-arginine and protein/amino acid loads.
尽管糖尿病患者或肾单位减少的个体有相关证据,但在无肾脏疾病的受试者中,蛋白质或氨基酸诱导的肾功能变化与尿白蛋白排泄(UAE)之间的实际关系很大程度上仍不清楚。在人类中,最近l-精氨酸输注已用于血管和肾脏病理生理学研究。本研究旨在分析一种特定效应所涉及的机制;即氨基酸负荷期间UAE的变化。通过静脉输注l-精氨酸对10名健康成年人进行了一项前瞻性干预方案。主要结果表明,l-精氨酸使UAE从输注前的13.1±3.8显著增加至输注后的53.3±11.1微克/分钟(P<0.005)。这一增加与肾小球滤过率(GFR)和肾血浆流量(RPF)的增加同时发生。此外,l-精氨酸显著增加了β2-微球蛋白的尿排泄。UAE与GFR(r = 0.738;P = 0.014)和RPF(r = 0.942;P<0.0001)显著相关,但与尿β2-微球蛋白(r = 0.05;P = 无显著性)无关。此外,发现UAE增加百分比(306.8%±163.2%)相对于白蛋白滤过负荷(FLAlb;57.9%±16.3%)和β2-微球蛋白排泄(1088.5%±424.6%)之间存在显著差异(P = 0.001)。输注载体的个体未发现变化。总之,本研究表明,在受控条件下,l-精氨酸输注可使健康个体的UAE显著增加,且显著超过仅由GFR增加所预期的水平。β2-微球蛋白排泄的强烈且同时增加强烈表明,l-精氨酸对UAE的影响在很大程度上是通过肾小管蛋白重吸收途径的阻断介导的。然而,l-精氨酸对UAE和β2-微球蛋白排泄诱导的变化中观察到的深刻差异以及UAE和β2-微球蛋白与GFR相关性的差异表明,l-精氨酸影响白蛋白和β2-微球蛋白肾脏处理的机制存在很大差异。这些发现对于理解肾脏对l-精氨酸和蛋白质/氨基酸负荷的反应具有重要意义。